
Baker Botts L.L.P.‘s antitrust practice, anchored in Washington DC and led by Paul Cuomo, is recognized for handling high-profile matters across the US and internationally. The team advises clients on complex civil and criminal litigation, as well as DOJ, FTC, and state investigations. Recent high-profile matters include representing Liberty Media and Formula 1 in DOJ and Congressional inquiries regarding Andretti Racing, defending EOG Resources in multidistrict shale oil litigation, and guiding Sun Pharmaceuticals, Taro Pharmaceuticals, and Avenue5 Residential through significant antitrust proceedings. The bench is strengthened by experienced partners including John Taladay, Erik Koons, Stacy Turner, and Jeffrey Oliver, whose expertise spans class actions, criminal and civil investigations, and cross-border regulatory matters.
Legal 500 Editorial commentary
Key clients
- Akamai Technologies, Inc.
- Amazon.com, Inc.
- American Industrial Partners, LLC (AIP, LLC)
- Avenue5 Residential
- Caterpillar Inc.
- Celanese Corporation
- CMC Materials, Inc.
- Enovis Corporation
- Envista Holdings Corporation
- EOG Resources
- Ericsson Inc.
- Formula One World Championship Limited
- Georgia-Pacific LLC (GP Wood Products LLC)
- Halliburton
- Koninklijke Philips N.V., Philips North America LLC, Philips Taiwan, Limited and Philips do Brasil Ltda.
- Liberty Latin America Ltd.
- Liberty Media Corporation
- Magellan Midstream Partners LP
- Masco Corporation
- National Association of Boards of Pharmacy
Work highlights
Represented Liberty Media and Formula 1 in connection with investigations by the US DOJ Antitrust Division and a Congressional committee regarding the proposed entry of Andretti Racing as a new entrant and team competing in the Formula 1 World Championship.
Representing EOG Resources in a class action lawsuit alleging that oil and gas producers conspired with OPEC to curb output of shale oil.
Defending Sun Pharmaceutical Industries and Taro Pharmaceutical Industries, in ongoing proceedings in the US District Court for the District of Connecticut brought by the attorneys general of 48 states and US territories, alleging that numerous of the largest generic pharmaceutical manufacturers conspired to inflate the prices of dozens of generic drugs putting at stake billions in damages.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Paul Cuomo
Other key lawyers
John Taladay; Erik Koons; Stacy Turner; Jeffrey Oliver


